A phase II study of bleomycin, oncovin, lomustine and DTIC (BOLD) in stage IV metastatic melanoma
Publication
, Journal Article
Seigler, HF; Lucas, VS; Pickett, NJ; Huang, AT
Published in: Proceedings of the American Association for Cancer Research
January 1, 1979
Duke Scholars
Published In
Proceedings of the American Association for Cancer Research
Publication Date
January 1, 1979
Volume
Vol. 20
Citation
APA
Chicago
ICMJE
MLA
NLM
Seigler, H. F., Lucas, V. S., Pickett, N. J., & Huang, A. T. (1979). A phase II study of bleomycin, oncovin, lomustine and DTIC (BOLD) in stage IV metastatic melanoma. Proceedings of the American Association for Cancer Research, Vol. 20.
Seigler, H. F., V. S. Lucas, N. J. Pickett, and A. T. Huang. “A phase II study of bleomycin, oncovin, lomustine and DTIC (BOLD) in stage IV metastatic melanoma.” Proceedings of the American Association for Cancer Research Vol. 20 (January 1, 1979).
Seigler HF, Lucas VS, Pickett NJ, Huang AT. A phase II study of bleomycin, oncovin, lomustine and DTIC (BOLD) in stage IV metastatic melanoma. Proceedings of the American Association for Cancer Research. 1979 Jan 1;Vol. 20.
Seigler, H. F., et al. “A phase II study of bleomycin, oncovin, lomustine and DTIC (BOLD) in stage IV metastatic melanoma.” Proceedings of the American Association for Cancer Research, vol. Vol. 20, Jan. 1979.
Seigler HF, Lucas VS, Pickett NJ, Huang AT. A phase II study of bleomycin, oncovin, lomustine and DTIC (BOLD) in stage IV metastatic melanoma. Proceedings of the American Association for Cancer Research. 1979 Jan 1;Vol. 20.
Published In
Proceedings of the American Association for Cancer Research
Publication Date
January 1, 1979
Volume
Vol. 20